Starling Oncology, Inc. Other Receivables, Net, Current
Starling Oncology, Inc. (DFPH) had Other Receivables, Net, Current of $360.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › and Others
us-gaap:OtherReceivablesNetCurrent · last filed 2026-08-06
- 2026-06-30: Other Receivables, Net, Current $360.00K.
- 2026-03-31: Other Receivables, Net, Current $1.32M.
- 2025-12-31: Other Receivables, Net, Current $322.00K.
- 2025-09-30: Other Receivables, Net, Current $339.00K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2026-06-30 | $360.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.32M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $322.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $339.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $276.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $346.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $346.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $358.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $350.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $368.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $551.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $464.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $499.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $428.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $617.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $559.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $422.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.28M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.24M 10-K · filed 2023-03-16 |
| 2020-12-31 | $113.00K 10-K · filed 2022-03-11 |